Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Department of Pediatrics, Division of Adolescent MedicineDocument Type
Journal ArticlePublication Date
2017-04-01Keywords
Human papillomavirusVaccine
Cervical cancer
Oropharyngeal cancer
Neoplasms
Pediatrics
Virus Diseases
Metadata
Show full item recordAbstract
Rates of cancers attributable to human papillomavirus (HPV) are rising. A safe and extremely effective vaccine is available to prevent many of these cancers. Studies have shown that health care providers' recommendation to immunize is the most important factor in parents' decision. Parents of all adolescent boys and girls should receive a strong and unequivocal recommendation to vaccinate their child against HPV at the 11- or 12-year-old well child visit. Ideally, adolescents complete their HPV vaccine series by their 13th birthday, leading to greater immune response and protection before most adolescents are exposed to sexually transmitted HPV.Source
Pediatr Clin North Am. 2017 Apr;64(2):321-329. doi: 10.1016/j.pcl.2016.11.003. Link to article on publisher's siteDOI
10.1016/j.pcl.2016.11.003Permanent Link to this Item
http://hdl.handle.net/20.500.14038/43562PubMed ID
28292448Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.pcl.2016.11.003